World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 April 2013
Main ID:  PACTR201302000478315
Date of registration: 01/01/2013
Primary sponsor: Dr Akaninyene Otu
Public title: A RANDOMISED CONTROL TRIAL COMPARING INTENSIVE WITH CONVENTIONAL EDUCATION FOR DIABETES MELLITUS PATIENTS IN CALABAR
Scientific title: A RANDOMISED CONTROL TRIAL COMPARING INTENSIVE WITH CONVENTIONAL EDUCATION FOR DIABETES MELLITUS PATIENTS IN CALABAR
Date of first enrolment: 2012-06-01
Target sample size: 100
Recruitment status: Open to recruitment: actively recruiting participa
URL:  HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201302000478315
Study type:  interventional
Study design:  Factorial: participants randomly allocated to either no,one,some or all interventions simultaneously,
Randomised,
Simple randomisation using a randomisation table from a statistics book,
Allocation was determined by the holder of the sequence who is situated off site,
 
Countries of recruitment
South Africa
Contacts
Name: Victor   Umoh
Address:  University of Calabar Teaching Hospital PMB 1278 Calabar Nigeria
Telephone: +2348055026582
Email: aaumoh@gmail.com
Affiliation:  Consultant Physician
Name: Akaninyene  Otu
Address:  University of Calabar Teaching Hospital PMB 1278 Calabar Nigeria
Telephone: +2348105723133
Email: akanotu@yahoo.com
Affiliation:  Consultant Physician
Key inclusion & exclusion criteria
Inclusion criteria: ? HBA1c b 8.5 % measured before randomization.
? Age b 18 years.
? Able to exercise.
? Available to participate if randomized in the program.
? Provision of written informed consent.

Exclusion criteria: ? Significant eye disease limiting visual acuity.
? Lower extremity amputation limiting exercise.
? No written informed consent.


Age minimum: 18 Year
Age maximum: 100 Year
Gender: Both
Health Condition(s) or Problem(s) studied

Diabetes Mellitus
Intervention(s)
Primary Outcome(s)
significant reduction in HbA1c after 6 months of intensive education
Secondary Outcome(s)
Secondary ID(s)
nil known
Source(s) of Monetary Support
Self funded
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history